ICRF 187.
Hellmann
K
K
Westminster Hospital, London, UK.
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D006331:Heart Diseases / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use*; D011929:Razoxane / Q000008:administration & dosage / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D010879:Piperazines; D011929:Razoxane; D004317:Doxorubicin